Viewing nowCombinationTelmisartan and Amlodipine Tablets 80/5 mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Handok Co., Ltd.

MFDS item code 201605770 · Approved 2016.09.30 · Insurance code 652105620
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with alone therapy of amlodipine or telmisartan. It helps to lower blood pressure more effectively and reduce cardiovascular risk. In other words, it is a suitable treatment option for hypertensive patients who do not respond to monotherapy.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, as follows, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication should not be used by pregnant women, especially during the second and third trimesters, as it can cause serious problems for the fetus. This drug should not be administered to patients with certain diseases, such as severe liver impairment, obstructive biliary disease, severe hypotension, or severe heart diseases. Patients with primary aldosteronism, specific heart valve diseases, liver impairment, gastrointestinal diseases, and renovascular hypertension require special caution while using this medication. Side effects like dizziness and peripheral edema can occur frequently, and serious side effects have been reported rarely, so medical consultation should be sought if unusual symptoms appear. Pregnant women should especially avoid taking this medication, and if pregnancy is confirmed, it must be stopped immediately, and alternative treatment should be arranged. Symptoms of hypotension may occur, so blood pressure and symptoms should be carefully monitored during the initial administration, and appropriate treatment should be sought if necessary. There is a risk of increased serum potassium levels; therefore, patients with impaired renal function or heart failure require regular blood tests. This medication may affect kidney function, so patients with kidney disease should monitor kidney function through blood tests as advised by their physician. Patients with cardiovascular diseases may have an increased risk of angina or myocardial infarction when taking this drug, and it should only be taken under medical supervision. This medication can cause drowsiness or dizziness, so caution is required when driving or operating dangerous machinery. There may be interactions when taken with other medications; therefore, it’s essential to inform the healthcare provider of any existing medications. Breastfeeding women should ideally avoid this medication and consult a doctor if necessary. It is not recommended for children or adolescents under 18 years, as its safety and efficacy have not been adequately confirmed. Elderly patients may respond sensitively to this medication, so it should be used cautiously with dose adjustments. In case of overdose, symptoms like hypotension, dizziness, and cardiac problems may occur, so immediate medical attention should be sought.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in an airtight container that blocks out light. Additionally, it is best stored at room temperature between 1 and 30 degrees Celsius. This helps to maintain the effectiveness of the medication.
White and light gray, double convex, oval tablets
30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Handok Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.